Viral Infections

  • Author: Jin S. Suh, MD, FACP; Humberto R. Jimenez, PharmD, BCPS, AAHIVP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 8/1/21 (What's New)

Summary

  • Several studies have shown that treatment of HSV-2 in coinfected patients may reduce their HIV-1 RNA modestly or reduce the risk of clinical progression, excluding patients on ART
  • However, because anti-HSV therapies do not prevent HIV transmission, they should not be used to delay HIV progression in the place of ART when ART is available[Celum 2010; CDC OI]

Action required

Keywords: Herpes Simplex Virus , Sexually Transmitted Diseases

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.